Inflammatix is behind TriVerity — a first-in-class rapid blood test that reads the body’s own immune response to tell emergency clinicians, in about thirty minutes, whether a patient is fighting a bacterial or viral infection and how likely they are to become severely ill. FDA-cleared in 2025, it gives emergency departments something they’ve never had: a way to spot the “sneaky sick” before they deteriorate.
Bringing a brand-new diagnostic category to market means educating a busy, skeptical clinical audience across every channel — and doing it with materials that look as sharp as the science. That’s where AMP comes in.
We run Inflammatix’s social presence end to end, turning dense clinical milestones into content that moves — FDA clearance, federal grant news, conference presentations, and the physicians championing the test in the field. When a partner hospital presents new data or a champion clinician gives a talk, we find the quote, cut the clip, and get it into the feed while the moment is still hot.
We also brought a new level of design to the brand: a refreshed, polished visual language carried across pitch decks, ED posters, event materials, and sales assets — so everything TriVerity touches looks like the first-in-class breakthrough it is.
It’s an embedded, week-in-week-out partnership: we act as their marketing team, keep the brand assets in order, and answer the phone when something needs to move fast.
